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Abstract
Background: The majority of low- and middle-income countries (LMICs) do not have adequate civil registration
and vital statistics (CRVS) systems to properly support health policy formulation. Verbal autopsy (VA), long used in
research, can provide useful information on the cause of death (COD) in populations where physicians are not
available to complete medical certificates of COD. Here, we report on the application of the SmartVA tool for the
collection and analysis of data in several countries as part of routine CRVS activities.
Methods: Data from VA interviews conducted in 4 of 12 countries supported by the Bloomberg Philanthropies
Data for Health (D4H) Initiative, and at different stages of health statistical development, were analysed and
assessed for plausibility: Myanmar, Papua New Guinea (PNG), Bangladesh and the Philippines. Analyses by age- and
cause-specific mortality fractions were compared to the Global Burden of Disease (GBD) study data by country. VA
interviews were analysed using SmartVA-Analyze-automated software that was designed for use in CRVS systems.
The method in the Philippines differed from the other sites in that the VA output was used as a decision support
tool for health officers.
Results: Country strategies for VA implementation are described in detail. Comparisons between VA data and
country GBD estimates by age and cause revealed generally similar patterns and distributions. The main
discrepancy was higher infectious disease mortality and lower non-communicable disease mortality at the PNG VA
sites, compared to the GBD country models, which critical appraisal suggests may highlight real differences rather
than implausible VA results.
Conclusion: Automated VA is the only feasible method for generating COD data for many populations. The results
of implementation in four countries, reported here under the D4H Initiative, confirm that these methods are
acceptable for wide-scale implementation and can produce reliable COD information on community deaths for
which little was previously known.
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Background
Informed health policy to reduce premature mortality
and improve population health requires reliable esti-
mates of the leading causes of death for the entire popu-
lation, not just those who die in hospitals where
physicians are available to certify the cause of death
(COD). However, comparatively few countries benefit
from reliable and timely evidence about who dies of
what, particularly lower- and middle-income countries
(LMICs) where the epidemiological transition is likely to
be advancing rapidly and where the need for such infor-
mation is arguably the most acute [1]. Recent assess-
ments of the quality of data from national civil
registration and vital statistics (CRVS) systems world-
wide suggest that only about one quarter of all countries
(55–60) have functioning systems that can adequately
support policy formulation and evaluation [2, 3]. In
LMICs, most deaths typically occur at home and are
often not registered, or if they are, are not certified by a
trained medical practitioner. Rather, the COD, if notified
at all, is generally assigned by non-medical untrained
personnel, resulting in a large fraction of ill-defined or
otherwise vague diagnoses that are of little value for
guiding policy to control the leading causes of death in
the population [4].
Traditionally, the development of a functional CRVS
system has taken countries such as Sweden, the UK and
Australia several decades, if not centuries, to achieve and
has generally required sufficient levels of national wealth,
education and supply of physicians before reliable statis-
tics on causes of death could be produced [5]. Circum-
venting this long delay by developing and implementing
low-cost, alternative and efficient methods to generate the
essential health intelligence for planning has thus become
an urgent and fundamental challenge for health measure-
ment strategies. Given the lack of trained physicians in
many LMICs, verbal autopsy (VA) is the only practical al-
ternative for collecting information on the leading causes
of death in such populations, and how they are changing.
VA involves trained local workers (often non-
physician health care workers) administering structured,
symptom-based questionnaires to the caretakers of the
deceased and transferring the responses to a database
where they are analysed using a method for assigning
the COD. Historically, physicians assigned a COD based
on the responses to the questionnaire [6]. Recent ad-
vances in methodological research and computer tech-
nology have automated this process whereby computer
algorithms analyse the responses to the questionnaires
and assign a COD, with significant cost and time savings
[7]. Automated diagnostic methods have the advantage
of standardisation, circumventing comparability prob-
lems arising from variations in physician judgement
across populations. Moreover, automated diagnostic
methods do not burden physicians with additional ad-
ministrative tasks that detract from their primary role of
delivering health care. A variety of algorithms have been
proposed, some making extensive use of data collected
in specialised demographic and health surveillance sites,
primarily in Africa, where the processes for interview
and data analysis are well established [8–11]. These sites
have demonstrated that community-based COD systems
using VA are certainly feasible, but the potential for VA
to be used on a routine basis in national CRVS systems
to provide essential information on broad population
COD patterns has only recently been evaluated under
the Bloomberg Philanthropies Data for Health (D4H)
Initiative [12–15].
In this paper, we report on experiences using SmartVA,
a specific data collection and diagnostic tool that has been
demonstrated to perform as well as, if not better than
most alternative methods, including physician-assigned
COD [16]. We draw a number of important conclusions
from our experience in adapting the automated VA
method from a research environment to a software tool
and demonstrate the considerable potential for automated
VA to be routinely applied in national CRVS systems to
dramatically improve the evidence base on who dies of
what in LMICs.
Methods
Country data collection
The D4H Initiative aims to strengthen CRVS systems in
countries. During the process of D4H country work plan
development, the need for better information on commu-
nity deaths, or a sub-set of deaths not currently captured
through medical certification of COD, was identified as
the highest priority, with most countries involved in D4H
committed to the implementation of VA to obtain this in-
formation. A 5-day training curriculum with associated
materials was developed and subsequently adapted to
country needs [17–19]. Since the aim is to use this infor-
mation to strengthen CRVS systems, the general module
of the VA questionnaire, concerned with administrative
information (such as date and place of death, usual resi-
dence, etcetera), was also adapted by countries to allow
such data to be incorporated into the current CRVS
system.
SmartVA has been translated and applied in several
D4H intervention countries, including Bangladesh,
Brazil, China, Colombia, Papua New Guinea (PNG), the
Philippines, Myanmar, Peru, Rwanda, Solomon Islands,
Sri Lanka and Zambia (Fig. 1). VA implementation
ideally follows a number of stages, through a pre-test,
pilot, demonstration stage and gradual scale-up [12].
Consequently, different numbers of VAs were collected
and processed using this methodology, reflecting the dif-
ferent stages of VA programme implementation across
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the D4H countries. To illustrate the challenges and
achievements of this methodology to rapidly improve
knowledge on causes of death in rural populations at
low cost, we report on the implementation of SmartVA
in four countries: Myanmar, PNG, Bangladesh and the
Philippines. These countries were selected to highlight
the application of SmartVA in countries at varied stages
of health statistical development.
Verbal autopsy questionnaire
For VA interview application in D4H countries, we used
the Open Data Kit (ODK) software, the most widely
used electronic data collection tool for VA. Data collec-
tion using ODK Collect on Android tablets and data
storage with ODK Aggregate have greatly improved data
quality [20]. The use of a common platform like ODK,
with the ability for translation of the VA questionnaire,
also enabled the use of automated VA in non-English-
speaking countries.
An important aspect of VA questionnaire design is the
time taken to conduct a VA interview. For routine appli-
cation in a country, which might well entail tens of
thousands of VAs every year, it is desirable that the
interview be as short as possible so as to minimise inter-
viewer and respondent fatigue and distraction, while still
reliably capturing essential diagnostic information. The
shortened version of the Population Health Metrics Re-
search Consortium (PHMRC) questionnaire was used in
SmartVA. This questionnaire was systematically short-
ened by about 50% from a longer version that was used
in research sites using item reduction methods, without
a significant decline in diagnostic performance [21].
Empirical evidence from the application of the shortened
SmartVA questionnaire suggests that the interview can
be completed in 20–22 min, on average, with a further
3–5 min required for the open narrative section [7, 22].
Tariff VA diagnostic algorithm
The Tariff VA diagnostic algorithm was originally devel-
oped by the PHMRC based on the premise that certain
symptoms are more strongly associated with certain spe-
cific causes than others [23]. The resulting ‘tariff’ scores
for each symptom-cause pair should, in principle, pro-
vide sufficient information to adequately discriminate
among various potential causes of death, depending on
the pattern of responses to the VA symptom question-
naire, and other information provided at the time of
interview. In other words, the diagnostic procedure
should be entirely data-driven (by the strength of the ob-
served tariff scores) and not dependent on expert opin-
ion. Subsequent developments of the Tariff algorithm
(Tariff 2.0) improved the diagnostic accuracy of the
method, by assessing predictive performance against a
large ‘Gold Standard’ diagnostic database of over 12,000
cases where the COD was reliably known, by refine-
ments to methods used to incorporate the ‘open narra-
tive’ (free-flowing text in the respondent’s words about
events leading up to death), and incorporating a recali-
bration of thresholds used to determine some specific
diagnoses based on experience with field application of
Fig. 1 Map of countries where SmartVA has been applied
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the method [9, 24]. Full details on the development and
performance characteristics of the Tariff method can be
found elsewhere [9, 16, 21, 23].
Comparative performance studies, where alternative
diagnostic methods were validated against the PHMRC
Gold Standard database, demonstrated that the Tariff
method was able to correctly predict COD fractions at
the population level, arguably the most relevant informa-
tion for policy, about 77% of the time, compared with
63–69% for other automated diagnostic methods such as
InterVA, and 68% when physicians were used to diag-
nose VA questionnaires [25].
Verbal autopsy software
We used SmartVA-Analyze version 2.0 to implement the
Tariff 2.0 method with the SmartVA questionnaire [26].
This version of SmartVA-Analyze has some important dif-
ferences from previous versions, such as more user-
friendly outputs for analysing and interpreting results. The
primary use of SmartVA-Analyze is to generate cause-
specific mortality fractions (CSMFs) to identify the leading
causes of death (as a fraction) in the community.
There are two main outputs from SmartVA-Analyze:
individual cause predictions and population distribution
of causes of death (i.e. CSMFs). Individual cause predic-
tions provide a COD for each VA interview completed,
along with those for which a cause assignment could not
be made with sufficient certainty based on the symptom
pattern reported by the family (an ‘undetermined’ COD).
The population distribution of causes of death, or the
CSMFs, aggregates the individual predictions from the
VA interviews and, in addition, redistributes the un-
determined causes of death among the causes that can
be diagnosed based on the evidence from the GBD and
the cause distribution of undetermined cases from a
comparison with gold standard diagnoses [9]. This redis-
tribution is done in two ways. Firstly, a VA with an un-
determined COD is fractionally distributed among all
VA causes, with weights proportional to the likelihood
that the particular cause was diagnosed as undetermined
in the gold standard database. Certain deaths (such as
pneumonia) are more likely to be reported as an un-
determined COD because the condition is inherently
more difficult to diagnose using VA methods than an
event such as a road traffic accident. Secondly, this frac-
tional redistribution weight is averaged with a propor-
tional redistribution weight selected according to the
GBD age-sex COD distribution for the country based on
the alignment with covariates and other determinants of
the epidemiological environment of a population that
the GBD measures. This redistribution is done at the
population level since the primary purpose of VA is to
correctly understand the COD patterns in populations,
not individuals.
A more recent use of VA, as an aid for physicians,
prompted the development of the second software appli-
cation: ‘SmartVA Auto-Analyze’. In the Philippines, it is
mandatory for municipal health officers to write a death
certificate for all non-facility deaths—even those for
which they had little or no contact with the deceased.
The software offers a standardised, logical, symptom-
based platform to elicit useful diagnostic information
from the family. The output of Auto-Analyze differs
from that of SmartVA-Analyze because it produces only
individual results. Physicians conduct the VA interview,
and Tariff 2.0 presents them with the top three most
likely causes of death along with the basic demographic
characteristics of the deceased and a full list of all symp-
toms endorsed by the family. The physician reviews this
information and, using any other information as avail-
able from the family, completes the death certificate—
choosing either one of the Tariff-assigned causes of
death or an alternative cause. Auto-Analyze has been
configured in English, Spanish and Chinese and is cur-
rently being trialled in selected countries, including
China, to standardise and enhance procedures for diag-
nosing home deaths.
Assessing the plausibility of CSMFs from VA
Routine collection of VA as part of the CRVS system is
a new but important challenge for most countries, and
as such, the data collected need to be understood and
interpreted carefully. To assist countries with this task,
we have proposed a series of steps that countries can
and should follow to assess the plausibility of their VA
CSMFs [27]. This method involves firstly describing the
VA implementation area and assessing the extent to
which it is similar or dissimilar to a (usually national)
comparator. For instance, if geographic features, popula-
tion age distribution or the epidemiological profile of the
VA population differs from the national average, CSMFs
will be expected to differ. Other factors to consider
include completeness of information on death reporting
in the VA population (are all deaths registered, and do
they all have a VA) and whether the age-sex distribution
of death makes sense given the profile of the VA imple-
mentation area. Some assessment of the VA CSMFs
against a comparator dataset is useful once the charac-
teristics of both datasets are understood. Under D4H, a
tool to accompany these guidelines has been developed
to assist and guide countries in how to systematically re-
view their VA data for plausibility [28].
Global Burden of Disease
In many LMICs, there are few sources of data that can be
used to compare against population COD information
produced through a routine application of VA. In order to
assess whether the CSMFs from the application of
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SmartVA to rural populations produced plausible results,
we compared the CSMFs and age distributions of deaths
from SmartVA to the findings from the Global Burden of
Disease Study 2017, which give estimated COD patterns
for each country, by sex and age [3]. The GBD study is a
systematic, scientific and comprehensive collaboration to
estimate patterns, levels and trends in the causes of death
and disability in countries for over 350 diseases and injur-
ies for each year since 1990. The estimates are modelled
based on the existing mortality, morbidity and covariate
data, corrected for known biases, and thus represent the
predicted levels and patterns of mortality given the covari-
ate values for factors likely to affect specific diseases and
injury outcomes, such as education, income, smoking
prevalence and diet. While the GBD estimates are not
strictly comparable to the outputs from SmartVA, since
the latter are generally limited to community deaths only,
the comparisons are still likely to be meaningful given that
community deaths are likely to account for the vast major-
ity of deaths in these countries. In all our VA country
samples, the numbers of neonatal and child deaths are too
low to conduct such a comparison. Therefore, we present
results for adult deaths only, which provide sufficient
numbers for comparison.
Results
In each of the D4H countries, the process of implemen-
tation involved a formative phase, including stakeholder
consultation, formation of a country-specific technical
working group, process mapping to understand the
CRVS process1 and translation and cognitive testing of
the questionnaire to ensure that respondents understood
the intent of the questions [12]. Each country carried
out a small-scale pilot followed by a larger-scale imple-
mentation of SmartVA in a defined sample. Monitoring
and evaluation of each phase were ensured by the tech-
nical working group. The pre-test, pilot and demonstra-
tion phases were evaluated using mixed-methods
including both qualitative (focus group discussions with
interviewers) and quantitative (analysis of causes of
death) methods.
Myanmar
In Myanmar, the majority of deaths (84%) occur in the
community, with COD assigned through lay reporting to
a midwife at the time of registering the death. This in-
formation is entered into the CRVS database and inte-
grated with medically certified deaths. Not only does
this results in vague or erroneous COD information for
the majority of deaths that happen in the community
that are registered, but often deaths are not registered at
all, leaving the government with very poor mortality data
on which to base their health policy. The Ministry of
Health and Sports (MoHS) and the Central Statistical
Organization (CSO) of Myanmar partnered with the
D4H initiative to increase registration and improve in-
formation on the cause of community deaths by using
automated VA, utilising basic health staff (midwives and
public health supervisors), mandated to collect this in-
formation. The SmartVA questionnaire was translated
into the Myanmar language and loaded into the ODK
Collect application on tablets. A pre-test (300 VA inter-
views) in 3 townships2 in 2 regions and 1 state was con-
ducted in 2016, and a pilot in 14 townships (11,238 VA
interviews) in the same 3 states and regions was com-
pleted in 2017 [29]. Minor adjustments to the question-
naire and process for scale-up (training, monitoring and
feedback) were informed by lessons from these early
stages of implementation.
Improved death registration practices and automated
VA were scaled up in 2018 to include 42 townships
across the country, with at least 2 townships in each
state and region and Nay Pyi Taw Union Territory.
These 42 townships covered a population of over 8.1
million, or around 16% of the total population of the
country. They were selected to be broadly representative
of the population of Myanmar. Within these 42 town-
ships, VA was conducted on all notified community
deaths that occurred between January and December
2018. Basic health staff and their supervisors were
trained in SmartVA methods for 5 days by national and
township VA master trainers from the MoHS and the
CSO. Data from the field was sent to a central server at
the CSO, downloaded, cleaned and analysed monthly
using SmartVA-Analyze, with output from the analysis
sent to the respective townships. Formal evaluations
were jointly conducted with local stakeholders, in July
2018 and January 2019, to assess the plausibility of the
findings in the context of GBD estimates for Myanmar
and local knowledge about the epidemiological environ-
ment [30].
Papua New Guinea
Mortality surveillance in PNG is at an early stage of de-
velopment, almost entirely derived at present from
health facility discharge summaries, the Discharge
Health Information System (DHIS). The discharge diag-
nosis is recorded in the same manner for deaths as for
discharges back to the community and does not allow
for multiple causes as in part A of the international
standard medical certificate of COD. The proportion of
all deaths in PNG captured by the DHIS is approxi-
mately 10–15%, as the majority of deaths occur in the
1See paper in this series: Better data for better outcomes: The
importance of business processes management in CRVS systems. 2A township in Myanmar refers to a ‘low-level’ local government unit.
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community and are rarely registered. There is no na-
tional mortality surveillance system capturing data for
community deaths.
PNG is currently rolling out an electronic National
Health Information System (eNHIS) that aims to collect
individual-level data from all health centres and hospi-
tals in the country using tablet devices with automated
upload to a server at the National Department of Health.
The initial design of eNHIS included a drop-down menu
for discharges, including deaths, that was not adequate
for reporting underlying COD. The collaboration with
D4H aimed to pilot systems for a comprehensive mortal-
ity surveillance system in PNG using eNHIS. This in-
volved testing strategies for community-level reporting
of deaths to enable notification and VA by health staff,
as well as collaboration with the developers of eNHIS to
enable reporting of medical certification of COD data
and VA data through the electronic system.
VA data collection in PNG was implemented in three
districts in 2018. The districts were selected to reflect
the diverse geographical and political landscapes across
PNG but were not intended to be a representative sam-
ple. Rather, they were selected to identify different chal-
lenges and potential solutions, to guide subsequent,
wider country implementation. The three districts were
Alotau, Milne Bay Province; Talasea, West New Britain
Province; and Tambul-Nebilyer, Western Highlands
Province. Training was provided for notifying agents in
each district to notify deaths to their nearest health
centre, and VAs were conducted by trained health
workers: health extension officers, nurses and commu-
nity health workers. An evaluation of preliminary find-
ings was conducted in the first quarter of 2019 by the
Department of Health and National Burden of Disease
Technical Advisory Group, which suggested a substan-
tially different COD pattern for the country than that es-
timated by the GBD Study.
Bangladesh
Bangladesh has no functioning routine CRVS system for
registering deaths and determining the COD. With sup-
port from the D4H Initiative, Bangladesh thus estab-
lished collaborative mechanisms between the health
sector at the community level and the local civil registrar
and provided training to community health workers
(staff with non-medical background) to report deaths
and conduct VA during their routine household visits.
A VA pilot intervention was first introduced in Kali-
ganj Upazila (local administrative area with a population
of 304,600) in 2016. The shortened version of the
SmartVA questionnaire was translated and tested in
local Bengali language, and an electronic local language
version was installed on Android tablets for administer-
ing VA. Community-based health workers (CHW) were
trained and mandated to identify deaths in the commu-
nity and help families complete the registration forms
and collect the associated certificates during their rou-
tine visits, as well as notify the events to the local regis-
tration office for official registration within 45 days of
occurrence. When death is identified, and following the
mourning period, the CHW arranges an appointment to
meet with the family to conduct a VA interview using
the tablet.
This pilot, known as the ‘Kaliganj Model’, was success-
ful, with a very high coverage of death registration (> 90%)
and VA administration [31]. Following this success, the
Government of Bangladesh scaled up the model to apply
in additional sub-districts (Upazila) in the country. From
2017 to March 2019, VA was rolled out in 13 sub-
districts, including all 5 sub-districts of the Gazipur Dis-
trict and at least 1 sub-district selected purposefully from
each of the 8 divisions of the country, covering a total
population of 4.8 million. VAs were administered in 13
sub-districts, and VA interview data were electronically
transferred from the community to an ODK aggregate
server.
Philippines
In the Philippines, SmartVA was used as a decision sup-
port tool to assist municipal health officers (MHOs) in
completing death certificates for deaths that occur in the
community. A technical working group identified 13
sites where a pre-test was conducted in 1 language to as-
sess feasibility and acceptability. The intervention in-
cluded training 127 MHOs in SmartVA Auto-Analyze
and medical certification of COD. Next, the intervention
was scaled up to 50 municipalities across 6 regions of
the country using 3 different languages. A mixed-
methods evaluation was performed using COD data and
group discussions with the MHOs and the Department
of Health. MHOs and information technology (IT) staff
were trained by D4H trainers over 3 days. Of the 5644
deaths, SmartVA was used to certify 4419 (78%); for the
remainder, MHOs considered that there was sufficient
information available in the medical records to certify
the cause without SmartVA. SmartVA was found to be
readily acceptable by the MHOs and family members
and has been incorporated into the routine workflow of
the MHOs.
Cause of death data from applications of SmartVA
The characteristics of the VA adult deaths collected in
each of the four countries are shown in Table 1.
Myanmar had the largest sample of deaths, followed by
Bangladesh, the Philippines and PNG. In all four coun-
tries, the number of male deaths outnumbered female
deaths. In Myanmar and the Philippines especially, fe-
males died at older ages than males.
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The age distribution of the country VA samples seen
in Table 2 was evaluated by comparing with the GBD
age estimates. In Myanmar and Bangladesh, the propor-
tion of deaths generally increased with age, closely mir-
roring the pattern of GBD deaths. The age distribution
of deaths in PNG was generally younger, with the high-
est proportion of deaths occurring between ages 50 and
69, similar to the age distribution of deaths suggested by
the GBD comparator data, reflecting the comparatively
high mortality among younger adults in the country than
elsewhere.
For policy, it is important to understand at what stage
a country is in its epidemiological transition. A conveni-
ent metric to do so is the distribution of deaths accord-
ing to the three broad cause groups of the GBD:
communicable, maternal, neonatal and nutritional con-
ditions; non-communicable diseases (NCDs); and injur-
ies. The cause distribution of SmartVA outputs for the
various countries according to these broad cause groups
is shown in Fig. 2, with and without undetermined
causes reallocated for Myanmar, PNG and Bangladesh.
Reallocation was not required in the Philippines as phy-
sicians determine the COD for any undetermined cases
produced through VA. The 95% confidence intervals
were considerably larger for the causes in PNG, where
the sample size was only 612, compared to causes in
Myanmar and Bangladesh with sample sizes of 39,331
and 12,320, respectively.
Generally, SmartVA predicted similar proportions of
deaths in the three broad cause categories compared to
the GBD estimates, except for PNG where SmartVA pre-
dicted a much lower fraction of NCD deaths among
adults than the GBD estimates and considerably more
injuries and communicable, maternal and nutritional
diseases. This result is in accord with other epidemio-
logical research in PNG and also with a local expert
opinion based on the demand for health care services
[32]. The VA-assisted CSMF for injuries in the
Philippines was less than that predicted by the GBD.
This discrepancy may have been due to injury-related
deaths undergoing either an autopsy for police investiga-
tion or certification in the hospital, rather than inclusion
in the VA-assisted sample. For all countries, the ranking
of causes was the same for both the undetermined and
reallocated causes.
The proportion of undetermined causes of adult
deaths (deaths for which there was not sufficient cer-
tainty to assign a COD) was around one in six (18%) in
Myanmar and Bangladesh (18%), but considerably lower
in PNG (6%) and the Philippines (5%). The low fraction
of undetermined deaths in PNG and the Philippines
most likely reflects the stronger symptom ‘signal’ for
Table 1 Characteristics of VA interviews processed by SmartVA-Analyze for Myanmar, Bangladesh, PNG and the Philippines (adult
deaths)
Country (year of data) Number of adult cases Male to female ratio in the sample (%) Age, median (IQR) years
Myanmar (2018) 39,331 56:44 Males, 62 (47–75)
Females, 72 (59–82)
PNG (2017) 612 60:40 Males, 54 (38–66)
Females, 52 (31–71)
Bangladesh (2017–2018) 12,320 62:38 Males, 66 (53–77)
Females, 69 (52–79)
Philippines (2018) 4267 55:45 Males, 65 (54–76)
Females, 72 (60–83)
Table 2 Age distribution of VA deaths compared to the GBD age distribution of deaths, selected countries
Age group
(years)
Myanmar PNG Bangladesh Philippines
VA, n (%) GBD (%) VA, n (%) GBD (%) VA, n (%) GBD (%) VA, n (%) GBD (%)
12–19 511 (1.3) 2 29 (4.7) 3.7 160 (1.3) 2.3 60 (1.4) 2.1
20–29 1219 (3.1) 4.2 82 (13.4) 9.6 382 (3.1) 3.2 115 (2.7) 4.7
30–39 2793 (7.1) 5.6 68 (11.1) 13.1 678 (5.5) 4 196 (4.6) 6.3
40–49 4208 (10.7) 9.1 80 (13.1) 17.5 1220 (9.9) 6.8 341 (8) 9.7
50–59 5664 (14.4) 15.1 88 (14.4) 19.8 1885 (15.3) 13.5 585 (13.7) 15.3
60–69 7591 (19.3) 20.5 111 (18.1) 19 2526 (20.5) 20.8 870 (20.4) 21.2
70–79 7906 (20.1) 21 82 (13.4) 12.8 2710 (22) 23.4 990 (23.2) 20.8
80+ years 9400 (23.9) 22.5 53 (8.7) 4.5 2587 (21) 26 1109 (26) 19.9
Unknown 39 (0.1) 0 19 (3.1) 0 172 (1.4) 0 0 (0) 0
Total 39,331 (100) 100 612 (100) 100 12,320 (100) 100 4267 (100) 100
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communicable and maternal causes in PNG, where these
conditions are more common (and so respondents are
better at symptom identification), and the direct involve-
ment of physicians in the Philippines in reviewing
SmartVA outputs and additional information provided
by the family at interview.
Discussion
Experience with SmartVA under the D4H Initiative sug-
gests that the method can be readily incorporated into
routine CRVS systems to reliably identify broad COD
patterns in communities, thus serving as an important
source of information for health sector priority debates.
The tool has also provided more detailed COD informa-
tion on the probable leading causes of death within each
of the broad cause groups, as required for the identifica-
tion and evaluation of health interventions. SmartVA
has proven to be an extremely useful tool in all countries
where it has been trialled to generate COD information
for populations, where hitherto there was no reliable in-
formation about who died of what. While the method-
ology has been introduced at different stages of
implementation in various countries, the four country
experiences reported here demonstrate that SmartVA
methods are feasible for large-scale collection and ana-
lysis of COD data for health policy purposes. The ease
Fig. 2 Distribution of level-1 GBD cause categories of VA deaths compared to GBD estimates. Group 1: communicable, maternal, and nutritional;
group 2: non-communicable diseases; group 3, injuries. *Distribution of level-1 GBD cause categories after mapping the VA-assisted causes of
death compared to GBD estimates for the Philippines, excluding 239 deaths which had been categorised as alcohol-related (3 deaths), other
respiratory (4 deaths), undetermined (146 deaths), and garbage codes (for 86 deaths). BR, before redistribution; AR, after redistribution; UD, undetermined; GC,
garbage code
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of uptake of SmartVA in countries from across the globe
highlights its usability and acceptability. A proportion of
VAs produce ‘undetermined’ causes of death, but this
fraction generally reduces once VA interviewers become
more competent in their understanding of VA and in
their interview techniques [30], underscoring the critical
importance of careful training and evaluation of inter-
viewer performance for any application of VA.
GBD is not a ‘gold standard’, and comparison with
other sources of data in a country, as well as the
characteristics of the VA population compared to the
population that GBD represents, is necessary. Indeed,
for PNG, the VA COD results suggest a lower frac-
tion of deaths from NCDs compared with the GBD
models, but the discrepancy with GBD is not unex-
pected by health experts in the country, many of
whom believe that GBD has overestimated the pro-
gress of the epidemiological transition, which is likely
to vary considerably across PNG [32]. For the other
countries, age distribution and pattern of broad
causes of death predicted by SmartVA were generally
consistent with that estimated for the same country
by the GBD both with and without undetermined
causes reallocated. Notwithstanding the caution of
using GBD estimates as a comparison, this does in-
crease the confidence in the utility of the outputs for
informing public health policy. In the comparisons
with GBD data, it is important to keep in mind that
SmartVA has only been applied to home (community)
deaths which could be expected to have a different
cause composition to deaths that occur in hospitals
and other health facilities. In addition, the age distri-
bution of death in PNG was skewed to higher ages in
the VA sample compared to GBD. In the absence of
a gold standard dataset to validate COD outputs from
the two approaches, it is difficult to judge which set
of data is likely to be more reliable and, to some ex-
tent, that is of lesser importance. What is important
is that the Ministry of Health in PNG can now bene-
fit from direct evidence, as opposed to model-driven
estimates, on the leading causes of death in a popula-
tion who do not regularly access health services, and
act accordingly.
The SmartVA methodology can be implemented to
achieve several health information system objectives.
For many countries, routine application of the
method in its simplest form, even on a sample of
home deaths captured by the CRVS system, will likely
yield highly informative and largely unbiased informa-
tion on the leading causes of death for deaths where
there has been little or no contact with the hospital
system. Other countries, for example, the Solomon
Islands, have used SmartVA to gather information
about ‘dead on arrival’ cases at major hospitals where
the COD is otherwise unattainable or to improve the
diagnostic accuracy of individual death certificates for
community deaths. Indeed, SmartVA Auto-Analyze
might be the optimal option for automated VA in in-
stances where individual death certificates are still
signed by a medical officer, given their diagnostic ac-
curacy is likely to be significantly enhanced, and stan-
dardised, by the information derived from the routine
application of the SmartVA Auto-Analyze tool. Other
hybrid versions, involving non-physicians collecting
VA information, with physicians reviewing the results
and assigning a COD, have also been successfully
trialled. The flexibility of the methods to accommo-
date local requirements has been an important factor
in the success of the intervention in the participating
countries.
VA implementation is complex and relies on several
phases: translation and transcultural adaptation of the
questionnaire and materials; intensive training of the
staff allocated to conduct the VA interview; rigorous
monitoring and supervision of these staff; and IT cap-
acity at different levels of the system to manage data
collection, transfer, analysis and dissemination. The
system-level considerations for VA implementation are
discussed elsewhere [12, 33]. Government investment
and commitment to the process is a pre-requisite for the
sustainability of this intervention. The continued com-
mitment of governments currently implementing VA in
D4H countries is indicative of the appreciation of the
benefits that such cost-effective, reliable and standar-
dised methods can yield for collecting information on
community deaths, often for the first time.
In terms of contribution to the strengthening of CRVS
systems in the country, VA has provided an impetus for
the improvement of community death registration prac-
tices that could be replicated in non-VA sites. For ex-
ample, in the Kaliganj pilot in Bangladesh, the
implementation of VA increased death registration from
30% in 2016 to 91% in 2018, and in Myanmar, increases
in registration completeness were seen in both pilot (14
townships) and country-wide scale-up (42 townships)
[30, 34]. Routine collection and analysis of data from
community deaths, the first time such an undertaking
has been attempted in some countries, is the first step
towards improving vital statistics. Ensuring that such
data can be routinely and reliably collected and then in-
tegrated with the existing or evolving CRVS infrastruc-
ture is another challenge that needs to be met [12].
Several important research and development priorities
have emerged from this initial global trial of integrating
SmartVA into routine CRVS systems as a means of im-
proving the availability and quality of COD data for pol-
icy and planning. The global health utility of SmartVA
(and VA software in general) could be greatly improved
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with the addition of new language versions, and particu-
larly through additional ‘gold standard’ data in order to
improve and expand (to other causes) the assessment
and validation of VA performance characteristics. VA
diagnostic algorithms would also benefit from a more ef-
ficient and comprehensive means of incorporating infor-
mation about local epidemiological environments as well
as from improving diagnostic procedures to derive max-
imum information content from the open narrative sec-
tion of the interview. Effectively integrating this new
source of COD data into current CRVS and health infor-
mation systems is also a key challenge. This involves
consideration of what data management tools are re-
quired, such as ‘CRVS/VA dashboards’ in order to moni-
tor data collection; how often, and where, remedial
interviewer training should be offered, including the role
of online training; and how VA data might be integrated
with other sources of mortality data collected by the
CRVS system. Efforts to integrate VA into the widely
used District Health Information System software
(DHIS-2) show promise [35]; however, incorporating this
information into existing CRVS systems will require a
high level of cooperation between agencies for data shar-
ing and strong IT capacity, something that is often lack-
ing in the statistical systems of developed and
developing countries alike.
Conclusions
Of the 55 million deaths that occur worldwide each
year, about 40% go unregistered; another 40% occur
in hospitals or health establishments where physicians
are available, in principle at least, to certify the COD;
and the remaining 20% are notified to authorities but
the underlying COD is either unknown or insuffi-
ciently specified to be of public health use [3]. Yet, to
improve population health for these (mostly) rural
communities where most deaths occur at home, effi-
cient mortality reduction strategies require reliable
COD information systems, and the only viable means
to do so is the routine use of automated VA. It is
simply not imaginable that requiring busy rural physi-
cians to do so on a regular basis is sustainable, des-
pite claims to the contrary [36]. Our experience
under the D4H Initiative in more than a dozen coun-
tries suggests that reliable methods such as SmartVA
can readily, cost-effectively and in a timely fashion
yield the essential information needed to guide public
policy [14, 15]. The results now being produced from
the country implementation of SmartVA, illustrated
here with data from Myanmar, PNG, Bangladesh and
the Philippines, confirm that these methods are ac-
ceptable for a wide-scale implementation and can
produce reliable COD information on community
deaths for which little was previously known. The
widespread application and integration of automated
VA into national CRVS systems in LMICs would
likely lead to a very substantial improvement in the
evidence base available for policy and planning and
for monitoring progress towards national and global
development goals.
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